top of page
Innovative Enhancement of Medicines
Innovative Enhancement of Medicines
LP Pharma focuses on unique formulation platforms for developing enhanced drug delivery options, including mucosal and oral controlled release, across a wide range of therapeutic areas.
LP Pharma has substantial product development experience in CNS, Oncology Supportive Care, and other specialty therapeutic areas.
We have successfully received multiple US FDA ANDA approvals. Our facilities include GMP-certified, commercial-scale manufacturing for solid dosage forms and injectables.
Pilot-scale manufacturing and technical services are available.
LP Pharma is actively seeking global commercial partners, especially or the US and European markets, and we are interested in in-licensing and partnerships for the China market.
bottom of page